...
首页> 外文期刊>Sensors and Actuators. B, Chemical >Separation of catecholamines and dopamine-derived DNA adduct using a microfluidic device with electrochemical detection
【24h】

Separation of catecholamines and dopamine-derived DNA adduct using a microfluidic device with electrochemical detection

机译:使用带电化学检测的微流控设备分离儿茶酚胺和多巴胺衍生的DNA加合物

获取原文
获取原文并翻译 | 示例
           

摘要

Dopamine (DA) can produce quinones that form protein and depurinating DNA adducts; the latter are thought to be involved in some neurode-generative diseases (e.g. Parkinson's disease) [E.L. Cavalieri et al., Carcinogenesis 23 (2002) 1071-1077]. Methods with high resolving power are needed to detect neurotransmitters (e.g. DA) and DA-derived DNA adducts in human fluids, as their presence is difficult to determine by standard chromatography with UV absorbance detection. We propose using microfluidic devices with an electrochemical (EC) detection system to determine the presence of DA, DA-6-A7Gua adduct, L-tyrosine, dihydroxyphenylalanine (L-DOPA), and catechol (used as an internal standard). A PDMS glass-based, hybrid microfluidic device for free solution electrophoresis with totally integrated electrodes as well as improved and simplified gated injection was fabricated and tested. The best position and optimal width for minimizing background current of the working electrode was experimentally established. Using a single power supply simplified the operation of the microfluidic device and provided control of the plug size (length), leading to increased separation quality. It is shown that excellent separation of the above analytes can be accomplished in a relatively short time; the response is linear in the range between 2 and 300 μM, and reproducible with a limit of detection (LOD) for DA-6-N7Gua adducts in the sub-femtomole range. Thus, future separation and identification of various neurotransmitters and/or their products in human fluids could be accomplished using microfluidic devices with electrochemical detection.
机译:多巴胺(DA)可以产生形成蛋白质并使DNA加合物脱嘌呤的醌。后者被认为与某些神经退行性疾病(例如帕金森氏病)有关。 Cavalieri et al。,Carcinogenesis 23(2002)1071-1077]。需要高分辨力的方法来检测人体液体中的神经递质(例如DA)和DA衍生的DNA加合物,因为它们的存在很难通过具有UV吸收检测的标准色谱法来确定。我们建议使用带有电化学(EC)检测系统的微流控设备来确定DA,DA-6-A7Gua加合物,L-酪氨酸,二羟基苯丙氨酸(L-DOPA)和邻苯二酚(用作内标)的存在。制作并测试了基于PDMS玻璃的,用于自由溶液电泳的混合微流体装置,该装置具有完全集成的电极以及经过改进和简化的门控进样。实验确定了最小化工作电极本底电流的最佳位置和最佳宽度。使用单个电源简化了微流体装置的操作,并提供了对塞子尺寸(长度)的控制,从而提高了分离质量。结果表明,可以在相对较短的时间内完成上述分析物的出色分离。该响应在2至300μM范围内呈线性关系,在亚甲孔范围内对DA-6-N7Gua加合物的检测限(LOD)可重现。因此,可以使用具有电化学检测的微流体装置来实现人体液中各种神经递质和/或其产物的未来分离和鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号